Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HHS OIG To Investigate Drug Shortages, Rebates, Other Pharma Issues In 2013

Executive Summary

A number of topical issues will be investigated by the HHS Office of Inspector General, according to its work plan for fiscal year 2013. Pharma industry issues are concentrated in the Medicare and Medicaid space.

Advertisement

Related Content

HHS Inspector General Investigating Drug Savings For Medicare In FY 2014 Work Plan
Reimbursement News, In Brief
Medicare Part D Plans Expanding Five-Tier Formularies, Preferred Networks In 2013
FDA Drug Shortage Staff Gets Higher Profile As New Reporting Requirements Begin
More Competition In Prostate Cancer? Medivation’s Enzalutamide Now With FDA
Senators Seek “Fresh” Ideas To Fight Health Fraud From Stakeholders
Nursing Home Overprescribing: Pharmacist Independence Requirement Should Start As Demo, APhA Says
HHS OIG Reviewing REMS, SBIR Eligibility, Patient Safety Organizations
OIG's 2012 Agenda Includes Several New Part D, Part B Drug Issues
CMS Proposes Compendia Publish All Materials Related To Listing Decision

Topics

Advertisement
UsernamePublicRestriction

Register

PS054793

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel